Open access peer-reviewed chapter

Acute Poisoning with Neonicotinoid Insecticide

Written By

Nicolai Nistor, Otilia Elena Frăsinariu and Violeta Ştreangă

Submitted: August 7th, 2017 Reviewed: October 27th, 2017 Published: December 20th, 2017

DOI: 10.5772/intechopen.72004

Chapter metrics overview

2,023 Chapter Downloads

View Full Metrics


Neonicotinoids are a class of insecticides considered less toxic to humans than organophosphates, carbamates, organochloride and pyrethroids. The purpose of this chapter was to systematize existing data in the literature on acute intoxication with neonicotinoids to help practitioners. Clinical manifestations vary across different human systems. Gastrointestinal symptoms consist of nausea, vomiting, abdominal pain and corrosive lesions. In the central nervous system, headaches, agitation, confusion, fasciculations, seizures or coma may occur, while tachycardia or bradycardia, hypertension, hypotension and palpitations occur in the cardiovascular system. Respiratory effects are dyspnea, aspiration pneumonia or respiratory failure. Solvents that drive the insecticide also have an important role in the toxic effects. There are no specific biological tests of neonicotinoid intoxication, and their dosing is not routinely available. Treatment is symptomatic. Mortality is less than 3%, well below the poisoning with anticholinesterase insecticides, like organophosphates and carbamates.


  • neonicotinoids
  • insecticides
  • poisoning
  • cardiovascular symptoms

1. Introduction

Poisoning with insecticides is a public health problem in many countries [1]. Organophosphates and carbamates are the principal cause of serious poisonings, sometimes leading to death. Due to the high toxicity of these compounds, new insecticides called neonicotinoids (synthetic analogs of nicotine) have been created [2].

The term “neonicotinoid” was initially used by Izuru Yamamoto for imidacloprid and related insecticides to differentiate the new insecticidal active compounds of n-AChRs from older nicotine insecticides [3].

Neonicotinoids are used in agriculture, horticulture and forestry to combat various pests. They are also used to combat fleas in domestic animals, as well as against household pests. After spraying, they act by direct contact with the insects, or by ingestion, when the insects pierce or consume the vegetative parts of plants [4]. Neonicotinoids are developed and continue to be launched on the market, often in the absence of direct human toxicity data. The human toxicity of these insecticides is often extrapolated from studies on animals, whose relevance is unclear. Therefore, more studies on acute intoxications with this class of insecticides are needed. The information resulting from these studies can contribute to the risk assessment and management of patients with neonicotinoid intoxications and support the decisions of the regulatory agencies for these substances [5]. The insecticidal activity of neonicotinoids results mainly from the agonist effect on the insects’ postsynaptic nicotinic receptors for acetylcholine. They are attached to the nicotinic receptors of the postsynaptic membranes from both nerve and muscle cells and thus disrupt the transmission of the nervous influx into the central and peripheral nervous system. Additionally, this interaction with the nicotinic receptors determines their desensitization, leading to a loss of synaptic transmission of the nervous impulse [6, 7]. In recent years, some studies have suggested that neonicotinoids have a negative impact on bees near crops exposed to neonicotinoids. It is known that exposure to thiamethoxam may cause bees to be disoriented [8, 9]. In 2013, the European Food Safety Agency published a report confirming that neonicotinoids pose a risk to bees and pollinators. For this reason, under the precautionary principle, the European Commission has decided to temporarily suspend the use of three neonicotinoid substances (imidacloprid, clothianidin and thiamethoxam) for seed treatment in the agriculture of all EU member States [10]. However, in some countries, based on derogations from the ministry, they are still used.

In a large study conducted recently in three countries in Europe (the United Kingdom, Germany and Hungary), the results were contradictory: in the United Kingdom and Hungary, neonicotinoids had a negative impact on bees, while in Germany they did not seem to have affected their health status [11]. The findings of another recent Canadian study, conducted in Ontario and Quebec, are that neonicotinoids have negative effects on bees, including a 23% decrease in their life span [12]. It is therefore necessary to continue the studies on this subject in order to reach a clear and definitive scientific conclusion. Neonicotinoid insecticides are considered to have low toxicity in humans because they interact much less with nicotinic receptors in vertebrates than in insects and penetrate less the blood-brain barrier. Provided that they are less toxic in humans, neonicotinoid insecticides have become increasingly used throughout the world. However, the ingestion of large amounts of these insecticides has been associated with the occurrence of severe poisoning [13].

Hence, this review was performed in order to clarify some aspects of the diagnosis and treatment of poisonings with neonicotinoids, useful for practitioners who face such cases and maybe helping improve management of these intoxications. The physicochemical properties, toxicokinetics, experimental data and mechanism of action of neonicotinoids, clinical symptoms, diagnosis, treatment and prognosis of acute intoxication with this relatively new class of insecticides are discussed below.


2. Physicochemical properties of neonicotinoids

Neonicotinoids are classified by the EPA as both Class II and Class III agents and are labeled with the signal word “Warning” or “Caution.” Imidacloprid, the first neonicotinoid insecticide discovered in 1994 in Japan, is a structural analogue of nicotine derived from N-nitroguanidine and is the best sold worldwide. Currently, besides imidacloprid, the neonicotinoid family includes thiamethoxam, clothianidin, thiacloprid, acetamiprid, dinotefuran, nitenpyram, nitiazine, imidaclothiz, flonicamid, sulfoxaflor and cycloxaprid, the chemical structure of which is shown in Figure 1 [14]. Currently, neonicotinoids are homologated in agriculture in more than 120 countries, being sold under various commercial names [14] (Table 1).

Figure 1.

Common names and molecular structures of the neonicotinoids [14].

Generation of neonicotinoidsType of neonicotinoidPhysical state
First-generation neonicotinoidsImidaclopridClear crystals or beige powder
NitenpyramPale yellow crystals
AcetamipridWhite crystals, white fine powder, odorless
ThiaclopridYellow crystalline powder, odorless
Second-generation neonicotinoidsThiamethoxamSlightly creamy crystalline powder, odorless
ClothianidinClear colorless solid powder, odorless
Third-generation neonicotinoidsDinotefuranWhite crystalline solid, odorless
SulfoxaflorWhite solid
CycloxapridWettable powder

Table 1.

The physical state of neonicotinoids.


3. Toxicokinetics

Most human toxicity data available are about imidacloprid. Penetration through the skin (predominantly in the agricultural environment) of neonicotinoid insecticides is not quantified in humans. Intoxication through the respiratory tract is negligible given that these molecules are nonvolatile. However, there may be a secondary swallowing of the inhaled aerosol microparticles. The first prospective study conducted in Sri Lanka by Mohamed F. et al. on 68 patients (61 with voluntary ingestion and 7 with cutaneous exposure) showed that the mean plasma concentration of imidacloprid was 10.58 ng/l, IQR: 3.84–15.58 ng/l, range: 0.02–51.25 ng/l. In seven patients, the plasma concentration remained elevated for 10–15 h postingestion, suggesting that absorption and/or elimination may be prolonged at high doses. The time-concentration profiles have demonstrated a rapid initial absorption [5]. The plasma peak is reached within 2 h. There is no preferential distribution in fat-rich tissues [15]. In insects, mammals and plants, neonicotinoids undergo phase I and phase II biotransformation (Figure 2).

Figure 2.

Sites of metabolite attack on IMI and 6-chloronicotinic acid (CNA) for phase I and phase II reactions [16].

In vitro studies on the metabolism of neonicotinoids have indicated the importance of cytochrome P450s (CYP) in their oxidation and reduction. Through a variety of human CYP isoenzymes, imidacloprid is oxidized to 5-hydroxyimidacloprid and imidacloprid olefin and reduced to nitrosoguanidine, aminoguanidine and urea imidacloprid. The most active CYP isoenzyme for oxidation of the imidacloprid residue is CYP 3A4 (CYP most abundant in humans), followed by CYP 2C19, 2A6 and 2C9. For nitroreduction, the most active CYP are: CYP 1A2, 2B6, 2D6 and 2E1 [16, 17].

Thiamethoxam is converted to clothianidin, which is more active than the parent molecule, mostly by CYP 3A4 and to a lesser extent by CYP 2C19 and 2B6, and is demethylated by 2C19. Clothianidin is demethylated by CYP 3A4, 2C19 and 2A6 [18]. There is no accumulation of neonicotinoids in the body: over 90% are eliminated in less than 24 h and totally in 48 h [15, 19].


4. Experimental data and mechanisms of action

Neonicotinoids are neither irritating to eyes and skin (rabbit) nor sensitizing (guinea pigs) [15]. Their acute toxicity to mammals is variable depending on the type of neonicotinoid. The amount of toxic product that kills 50% of the experimental animals, called the lethal dose (LD 50), is illustrated in Table 2 for the main neonicotinoids.

Common nameLocal effectsRat oral LD50Rabbit dermal LD50

Table 2.

Neonicotinoid pesticides mammalian toxicities (mg/kg of body weight) [7].

With an LD 50 of 425–475 mg/kg administered orally in rats, the toxicity of imidacloprid is mild to moderate. A single 42 mg/kg dose has no effect. After 2–6 h, poisoned animals present with apathy, trembling with ataxia, hypothermia and respiratory arrest [19, 20].

Neonicotinoids have been designed to be effective as insecticides by contact or ingestion [21]. In both insects and humans, neonicotinoids behave as postsynaptic acetylcholine receptor agonists, which are neurotransmitters of the central nervous system, the parasympathetic nervous system and some of the sympathetic system. Their irreversible linkages with these receptors initially stimulate, then rapidly block the Na+/K+ channels and inhibit the transmission of the nervous influx. Their high insect toxicity is explained by the predominance of nicotinic receptors in the central nervous system of these species, by the absence of the blood-brain barrier and by their affinity for some insect-specific receptor subtypes, in particular α4β2 [19]. In mammals, the predominant receptor subtype is α4p2, which is found to have the highest density in the thalamus. In the developing brain, this subtype is involved in proliferation, apoptosis, migration, differentiation, synapse formation and neuronal circuits [22]. Given that in mammals nicotinic receptors have a wider distribution (neuromuscular junction), the neonicotinoid affinity for these receptors is lower and the central action is reduced because of poor intracerebral penetration [17]. The toxicity of imidacloprid is very low in dermal exposure and is moderate in case of ingestion. In case of inhalation, the toxicity is variable: as dust it is considered to be slightly toxic, but as aerosols it is very toxic [23].


5. Epidemiology of acute poisoning with neonicotinoids in humans

Despite the widespread use of neonicotinoids, there are few reports in the literature on human toxicity. The first case report was made in 2001 by Wu IW et al. Clinical manifestation included drowsiness, disorientation, dizziness, oral and gastroesophageal erosions, hemorrhagic gastritis, productive cough, fever, leukocytosis and hyperglycemia. The patient recovered without complications with supportive treatment and was discharged 4 days after ingestion [24]. Most cases were reported in USA (Texas), France, China and Sri Lanka [25, 26, 13]. The epidemiological aspects resulting from these studies are summarized in Table 3.

StudiesCohort of the studyCountry of studyEpidemiological findings
Forrester M et al., 2014 [25]1142 cases of acute intoxication reported by Texas Intoxication Control Centers over the period 2000–2012 (retrospective study)USA
  • 77% with imidacloprid

  • 17% with dinotefuran

  • 64% female

  • 32 serious cases (2.9%)

  • Intoxication mode: ingestion (51%), cutaneous (44%) and ocular (11%)

  • 28% children aged <5 years and 9% aged 6–19 years

  • 97% accidental

Boels D, Chataigner D, 2014 [26]482 cases of acute poisoning with imidacloprid between January 1999 and December 2012 (retrospective study)France
  • Increase from 8 cases in 1999 to 34 cases in 2012

  • 120 cases (28%) were children <5 years

  • 37 cases (8.6%) children aged 5–14 years

  • 389 poisonings were accidental, 24 voluntary, and in 15 cases it was not possible to specify the circumstances of intoxication

  • Seven cases were serious, requiring intensive care

Phua DH et al, 2009 [13]70 cases of acute intoxication reported by the Taiwan National Poison Center between 1987 and 2007 (retrospective study)China
  • Dramatic increase in the number of cases between 2003 and 2007: 58 cases out of the total of 70

  • Two children with accidental poisoning

  • 67 males

  • 48 cases were suicidal attempts, of which eight consumed ethanol

  • Toxic: imidacloprid (64 cases), acetamiprid (4) and clothianidin (2).

  • Two deaths (mortality rate 2.9%)

Mohamed F et al., 2009 [5]68 cases of acute poisoning with imidacloprid between March 2002 and March 2007 (prospective study)Sri Lanka
The dosing was done in laboratories in Australia
  • 61 out of 68 patients (91%) were intoxicated by ingestion

  • 82% were voluntary poisonings

Table 3.

The main epidemiological aspects of neonicotinoid intoxication studies.

The prevalence of voluntary intoxication was different from one study to another: only 2% in the study in Texas and 4.9% in the study in France, as opposed to the studies in China and Sri Lanka, where 81% and 82%, respectively, were classified as an attempt of suicide [25, 26, 13].

There are also differences in childhood poisoning frequency: in the study conducted in Texas, 37% were patients under the age of 19, and in France 36.6% were children under the age of 14, whereas the study in China recorded only two children with accidental poisoning. The study in Sri Lanka does not specify the age of the patients.

Regarding the manner of intoxication, in the US study only 51% of poisoning occurred through ingestion, compared to 91% (61/68 cases) in Sri Lanka and 81% (57/70) in China.

In addition to these studies, several sporadic cases have been reported. Thus, eight cases were reported in India [2733], two in Turkey [34, 35], two in Portugal [36], two in Colombia [37], two in Japan [38], one case in Saudi Arabia [39], Iran [40], Poland [41] and four cases in Taiwan [4145].


6. Clinical symptoms of poisoning by neonicotinoids

Symptoms of neonicotinoid poisoning appear to be less severe in humans than in insects, because their affinity for human nicotinic receptors is lower and they do not cross the blood-brain barrier. Clinical picture is better known for intoxication with imidacloprid, which is the oldest neonicotinoid used as an insecticide. A large study conducted in Texas between 2000 and 2012 on 1142 patients with neonicotinoid exposure found that the main symptoms are: eye irritation and dermatitis, nausea, vomiting, corrosive oral mucosal lesions, dizziness, hypertension and tachycardia [25]. The French Toxicity Co-ordination Committee analyzed 428 cases of exposure to imidacloprid between 1999 and 2012, of which over 27% were children under 5 years of age. As a result of this study, the symptomatology was better outlined according to the severity of the intoxication (mild, moderate or severe), as illustrated in Table 4 [26].

SymptomatologyBenign forms
Minor, mild symptoms that spontaneously regress
Moderate forms
Pronounced or prolonged symptoms or signs
Severe forms
Severe symptoms that threaten vital prognosis
  • Sleepiness, vertigo, ataxia, tinnitus

  • Glasgow score 12–14

  • Slight agitation

  • Minor extrapyramidal symptoms

  • Minor cholinergic/anticholinergic symptoms

  • Paresthesia

  • Minor visual and hearing impairments

  • Disturbances of consciousness with delayed response to pain

  • Glasgow score 8–11

  • Apnea, bradypnea

  • Confusion, agitation, hallucinations, delirium

  • Localized or generalized seizures (rarely)

  • Marked extrapyramidal symptoms

  • Noticeable cholinergic/anticholinergic symptoms

  • Isolated paralysis without affecting vital functions

  • Visual and auditory disturbances

  • Deep coma with inappropriate or absent response to pain

  • Glasgow score 3–7

  • Depression or respiratory failure

  • Extreme agitation

  • Generalized seizures

  • Convulsive state, opisthotonus

  • Generalized paralysis or paralysis that affects vital functions

  • Blindness, deafness

  • Irritation, conjunctival hyperemia, tears

  • Minor eyelid edema

  • Marked irritation

  • Limited, circumscribed corneal involvement

  • Punctual keratitis

  • Corneal ulcer

  • Corneal perforations

  • Definitive sequelae

  • Irritation, first-degree burns

  • Second-degree burns and <10% body surface area (BSA)

  • Second-degree burns with 10–50% BSA to adult and 10–30% BSA to child

  • Third-degree marks <2% BSA

  • Second-degree burns >50% BSA to adult and >30% BSA to child

  • Third-degree burns >2% BSA

  • Edema, localized pruritus

  • Discrete pain

  • Localized edema involving the entire member

  • Localized necrosis

  • Moderate pain

  • Extensive edema comprising the adjacent member and the adjacent parts

  • Critical location of edema with danger to the integrity of the upper airways

  • Slight or moderate pain

  • Sensitivity to palpation

  • Rhabdomyolysis

  • CPK: 250–1500 ui/l

  • Pain, stiffness, cramps

  • Fasciculations

  • Rhabdomyolysis

  • CPK: 1500–10,000 ui/l

  • Intense pain, extreme rigidity

  • Extensive cramps

  • Extended, diffuse fasciculations

  • Rhabdomyolysis with complications

  • CPK > 10,000 ui/l

  • Compartment syndrome

  • Proteinuria and/or minimal hematuria

  • Proteinuria and/or massive hematuria

  • Oliguria, polyuria

  • Serum creatinine: 200–500 mmol/l

  • Kidney failure, anuria

  • Serum creatinine >500 μmol/l

  • Minor hemolysis

  • Methemoglobinemia ranging from 10 to 30%

  • Hemolysis

  • Methemoglobinemia ranging from 30 to 50%

  • Coagulation disorders without bleeding

  • Anemia, leukopenia, thrombocytopenia

  • Massive hemolysis

  • Methemoglobinemia >50%

  • Coagulation disorders with bleeding

  • Anemia, leukopenia, severe thrombocytopenia

  • ASAT, ALT: 2–5 times normal

  • ASAT, ALAT: 5–50 times normal

  • Without obvious clinical signs of liver dysfunction

  • ASAT, ALT >50 times normal

  • Affecting clotting factors

  • Clinical signs of liver failure

Table 4.

The symptomatology of imidacloprid poisoning depending on severity [26].

There was reported a case with concomitant intoxication with imidacloprid and alcohol ingestion, resulting in multiple organ failure [45]. Another case was reported by Agarwal and Srinivas, manifesting severe neuropsychiatric disorders and rhabdomyolysis [31]. In Colombia, Estrada et al. signaled two cases admitted with digestive manifestations, coma (Glasgow score 6 and 3, respectively) and respiratory failure with 70–75% Sa O2. One of the patients also presented dormant miosis and was thus given atropine [37]. In Saudi Arabia, there was a case with generalized erythematous maculopapular rash typical of leukoclastic vasculitis, which was confirmed by biopsy. It also associated hepatic and renal dysfunction, requiring dialysis [40]. Another case reported in Taiwan presented fatal ventricular fibrillation [45].

The main symptoms of acetamiprid poisoning are severe nausea, vomiting, muscle weakness, hypothermia and convulsions [46]. Clinical manifestations include tachycardia, hypotension, electrocardiogram changes, hypoxia and thirst in the case of the highest serum concentration of acetamiprid. The symptoms were partly similar to acute organophosphate intoxication [30]. In one case, ventricular fibrillation that lasted 11 h after ingestion was described [45]. Similar to imidacloprid poisonings, there was reported a case of severe multiple organic dysfunction [43]. Another case of acetamiprid intoxication was by suicidal ingestion, where symptoms included prolonged muscle weakness, similar to the intermediate syndrome in organophosphorus intoxication. The case resolved in about 3 weeks [35].

Symptoms of thiamethoxam intoxication are less known, and cases are rarely reported. Vinod et al. noted a case manifesting nausea, vomiting, agitation and multiple episodes of generalized tonic-clonic seizures within the first 2 h of ingestion of thiamethoxam. Subsequently, coma, hypotension, renal failure, metabolic acidosis and rhabdomyolysis occurred, with fatal outcome 36 h after ingestion [29].

Solvents used in neonicotinoid insecticide solutions can also play an important part in poisoning symptoms. Although not all solvents contained by neonicotinoid insecticides are known, most of them use N-methylpyrrolidone. Ingestion of a large amount of this substance irritates the upper gastrointestinal tract and causes oral ulceration, nausea, vomiting, dysphagia, odynophagia and abdominal pain [24].


7. Diagnosis of poisoning incidents

The diagnosis is based on anamnesis and clinical symptoms. There are no specific abnormalities of acute poisoning with neonicotinoids [5]. There may be metabolic disturbances (Table 5). Dosage of neonicotinoids is not routinely available, its interest being purely medicolegal. Depending on the symptomatology of each case, additional investigations may be necessary.

Clinical formsMildModerateSevere
Acidobasic disorders
  • HCO3: 15–20 or 30–40 mmol/l

  • pH: 7.25–7.32 or 7.50–7.59

  • HCO3: 10–14 sau > 40 mmol/l

  • pH: 7.16–7.24 sau 7.60–7.69

  • HCO3 < 10 mmol/l

  • pH < 7.15 or >7.7

Electrolytic disorders
  • K: 3–3.4 or 5.2–5.9 mmol/l

  • Moderate hypoglycemia: 0.5–0.7 g/l or 2.8–3.9 mmol/l

  • Short-term hyperthermia

  • K: 2.5–2.9 or 6–6.9 mmol/l

  • Severe hypoglycemia: 0.3–0.5 g/l or 1.7–2.8 mmol/l

  • Prolonged hyperthermia

  • K: <2.5 or >7 mmol/l

  • Severe hypoglycemia <0.3 g/l or <1.7 mmol/l

  • Malignant hyperthermia/hypothermia

Table 5.

Metabolic disorders depending on the severity of intoxication [26].

Depending on the intensity and duration of cardiovascular, respiratory and digestive symptoms, three degrees of severity can be distinguished (Table 6):

  1. Benign: mild symptoms that spontaneously regress;

  2. Moderate: pronounced or prolonged symptoms/signs;

  3. Severe: severe symptoms that may influence the vital prognosis.

FormsCardiovascular symptomsRespiratory symptomsDigestive symptoms
  • Isolated extrasystoles

  • Discrete, transient hypotension

  • Transient, discrete hypertension

  • Airways irritation

  • Coughing, breathlessness

  • Slight dyspnea

  • Slight bronchospasm

  • Abnormal thoracic radiography with or without minor symptoms

  • Vomiting

  • Diarrhea

  • Abdominal pain

  • Minor oral ulceration

  • Endoscopy: erythema, stage I edema

  • Sinus bradycardia:

    • Adults 40–50 b/min

    • Children 60–80 b/min

    • New born 80–90 b/min

  • Frequent premature beats

  • Atrial flutter/fibrillation

  • AVB grade I or II

  • Prolonged QRS and QTc

  • Repolarization modifications

  • Myocardial ischemia

  • Hypo/hypertension

  • Prolonged cough

  • Stridor, bronchospasm

  • Dyspnea

  • Hypoxia requiring oxygen administration

  • Abnormal pulmonary radiography with moderate symptoms

  • Pronounced or prolonged vomiting

  • Diarrhea

  • Abdominal pain

  • First-grade burns of a critical area or II and III grade burns on limited areas

  • Dysphagia

  • Endoscopy: stage IIa transient ulcerative lesions

  • Severe sinus bradycardia:

    • Adults <40 b/min

    • Children <60 b/min

    • New born <80 b/min

  • Severe sinus tachycardia

    • Adults >180 b/min

    • Children >190 b/min

    • New born >200 b/min

  • Ventricular dysrhythmia with vital prognosis

  • AVB grade III

  • Asystole

  • Myocardial infarction

  • Shock

  • Malignant hypertensive disorder

  • Respiratory failure: severe bronchospasm, dyspnea, airway obstruction, ARDS, pulmonary edema, glottis edema, bronchopneumonia, pneumopathy, pneumothorax

  • Abnormal pulmonary radiography with severe symptoms

  • Severe digestive hemorrhage

  • Digestive perforation

  • Enlarged II and III grade burns

  • Severe dysphagia

  • Endoscopy: transmural ulcer lesions, circumferential lesions, perforations stage IIB, III and IV

Table 6.

Degrees of severity according to intensity and duration of cardiovascular, respiratory and digestive symptoms [26].

Differential diagnosis should take into account intoxications with other pesticides. This poisonings can mimic light forms of organophosphorus or carbamates intoxications. Also, many cases reported involved combinations of multiple pesticides and ethanol [5, 13].


8. Management of poisoning incidents

Management of acute neonicotinoid insecticide poisoning is mainly symptomatic and supportive. Dermal and mucosal exposures should be decontaminated as soon as possible [13].

In case of coma and respiratory distress, intubation and assisted ventilation associated with hemodynamic support are required. The presence of solvents in liquid neonicotinoid formulas makes the activated charcoal and gastric lavage or vomiting ineffective, due to the risk of inhalation pneumonia [13]. Gastric lavage and activated charcoal should be avoided if corrosive injuries of the oral and gastrointestinal mucosa are found. Activated charcoal may hinder endoscopic evaluation of patients with corrosive lesions [13]. Prudent aspiration of the gastric contents can be considered, with respiratory protection, and if the ingested volume is high (over 100 ml), the ingestion period is short (less than 1 h) [13, 15]. The respiratory effects of neonicotinoids should be carefully monitored, particularly hypoventilation and respiratory failure. Patients with upper airway injuries such as hoarseness and stridor caused by irritant and corrosive effects of the solvent should probably undergo endoscopic assessment of vocal cordons [13].

Sometimes, organophosphorus intoxication may also be associated. In this case, acute poisoning may be manifested by miosis, bradycardia, hypersalivation and bronchorrhea. Because of these symptoms, atropine and oximes may be improperly used as an antidote. It is unknown whether these drugs are effective or may worsen the outcome of neonicotoid insecticide poisonings. In cases with life-threatening muscarinic manifestations (e.g., bronchorrhea with airway compromise), the use of atropine may be justified in neonicotinoid-poisoned patients [13, 44]. Oximes (e.g., pralidoxime) are usually either ineffective or contraindicated. In the absence of organophosphorus pesticides, oximes have a weak inhibitory effect on acetylcholinesterase activity and therefore may increase nicotinic effects (tachycardia, hypertension and muscle weakness) [5]. Because the severity of poisoning is not proportional to the plasma concentration of neonicotinoids, hemofiltration is ineffective in increasing their elimination [13, 43].


9. Prognosis and comparative mortality rates

The numbers of neonicotinoid poisonings have increased in the last decade, given that neonicotinoid insecticide is highly used. Respiratory, cardiovascular and certain neurological presentations (dyspnea/apnea, coma, tachycardia, hypotension, mydriasis and bradycardia) are symptoms of severe neonicotinoid intoxication [43]. Biochemical abnormalities and rhabdomyolysis have been reported as potentially serious complications that might lead to mortality [5].

Mortality through imidacloprid poisoning ranges from 0% to 4.2% in various studies. In a study in Taiwan, neonicotinoid poisoning mortality was 2.9%, inferior to that with organophosphates (12.3%) or carbamates (7.3%), but close to that with synthetic pyrethroids (3.1%) [47]. In the study in France conducted on 428 patients with acute neonicotinoid poisoning, six deaths were recorded [26]. Another study in Korea on 24 cases shows a mortality rate of 4.2% [48]. In addition to these studies on larger cohorts of patients, sporadic cases of acute neonicotinoid poisoning deaths are also reported in the literature (Table 7).

Authors, year of the studyPlace of studyThe type of neonicotinoidDeath numbers
Proença P et al., 2005 [36]PortugalImidacloprid2
Huang NC et al.,2006 [45]TaiwanImidacloprid1
Shadnia S et al., 2008 [40]IranImidacloprid1
Yeh IJ et al., 2010 [44]ChinaImidacloprid1
Iyyodurai R et al., 2010 [30]IndiaImidacloprid1
Harish J et al., 2011 [49]IndiaImidacloprid1
Fuke C et al., 2014 [49]JapanImidacloprid1
Vinod KV et al., 2015 [29]IndiaThiacloprid1

Table 7.

Deaths by acute poisoning with neonicotinoids reported in the literature.


10. Concluding remarks

Neonicotinoids act quite selectively on insects, but they are not free of human toxicity. Several cases of acute intoxication with such insecticides, sometimes severe, resulting in death, have been reported in the literature. The above review has highlighted the consequences of poisoning with these newer pesticides, not very well known at the moment. Therefore such information is valuable for clinicians, regulatory authorities and the public at large. Given the fact that these insecticides are increasingly being used in agriculture, horticulture and fish farming, but also for combating domestic pests, more studies on the human health effects of neonicotinoids exposure are needed and maybe some awareness programs about its toxicity should be implemented.


  1. 1. Konradsen F. Acute pesticide poisoning-a global public health problem. Danish Medical Bulletin. 2017;54(1):58-59
  2. 2. Cimino AM, Boyles AL, Thayer KA, Perry MJ. Effects of neonicotinoid pesticide exposure on human health: A systematic review. Environmental Health Perspectives. 2017;125(2):155-161. DOI: 10.1289/EHP515
  3. 3. Thany SH. Neonicotinoid insecticide: Historical evolution and resistance mechanism. In: Thany SH, editor. Insect Nicotinic Acetylcholine Receptors. New York: Springer Science; 2010:75-80
  4. 4. Simon-Delso N, Amaral-Rogers V, Belzunces LP, Bonmatin JM, Chagnon M, Downs C, Furlan L, et al. Systemic insecticides (neonicotinoids and fipronil): Trends, uses, mode of action and metabolites. Environmental Science and Pollution Research. 2015;22:5-34. DOI: 10.1007/S11356-014-3470-Y
  5. 5. Mohamed F, Gawarammana I, Robertson TA, Roberts MS, Palangasinghe C, Zawahir S, Jayamanne S. Acute human self-poisoning with Imidacloprid compound: A neonicotinoid insecticide. PLoS One. 2009;4(4):e5127. DOI: 10.1371/journal.pone.0005127
  6. 6. Roberts JR, Karr JC. Pesticide exposure in children. Pediatrics. 2012;130(6):e1765-e1788. DOI: 10.1542/peds.2012-2758
  7. 7. Fishel FM. Pesticide Toxicity Profile Neonicotinoid Pesticides. University of Florida, Florida; 2016. Available from:
  8. 8. Henry M, Béguin M, Requier F, et al. A common pesticide decreases foraging success and survival in honey bees. Science. 2012;336:348-350. DOI: 10.1126/science.1215039
  9. 9. Fischer J, Müller T, Spatz A-K, et al. Neonicotinoids interfere with specific components of navigation in honeybees. PLoS One. 2014;9:e91364. DOI: 10.1371/journal.pone.0091364
  10. 10. Proposition de resolution relative à la préservation des insectes pollinisateurs, de l'environnement et de la santé et à un moratoire sur les pesticides de la famille des néonicotinoïdes. 2014. Available from:
  11. 11. Woodcock BA, Bullock JM, Shore RF, Heard MS, Pereira MG, Redhead J, Ridding L, et al. Country-specific effects of neonicotinoid pesticides on honey bees and wild bees. Science. 2017;356(6345):1393-1395. DOI: 10.1126/science.aaa1190
  12. 12. Tsvetkov N, Samson-Robert O, Sood K, Patel HS, Malena DA, Gajiwala PH, Maciukiewicz P, et al. Chronic exposure to neonicotinoids reduces honey bee health near corn crops. Science. 2017;356(6345):1395-1397. DOI: 10.1126/science.aam7470
  13. 13. Phua DH, Lin CC, ML W, et al. Neonicotinoid insecticides: An emerging cause of acute pesticide poisoning. Clinical Toxicology. 2009;47:336-341. DOI: 10.1080/15563650802644533
  14. 14. Kasiotis KM, Machera K. Neonicotinoids and their metabolites in human biomonitoring: A review. Hellenic Plant Protection Journal. 2015;8:33-45. DOI:
  15. 15. Testud F. Insecticides néonicotinoïdes. EMC—Pathologie professionelle et l’environnement. 2014;9(10):1-6
  16. 16. Swenson TL. Neonicotinoid Insecticide Metabolism and Mechanisms of Toxicity in Mammals. Berkeley: University of California; 2013
  17. 17. Casida JE. Neonicotinoid metabolism: Compounds, substituents, pathways, enzymes, organisms, and relevance. Journal of Agricultural and Food Chemistry. 2011;59(7):2923-2931. DOI: 10.1021/jf102438c
  18. 18. Shi X, Dick RA, Ford AK, Casida JE. Enzymes and inhibitors in Neonicotinoid insecticide metabolism. Journal of Agricultural and Food Chemistry. 2009;97(11):4861-4866. DOI: 10.1021/jf900250f
  19. 19. Sheets LP. Imidacloprid: A neonicotinid insecticide. In: Krieger RI, editor. Handbook of Pesticide Toxicology. 2nd ed. San Diego: Academic Press; 2001. pp. 1123-1130
  20. 20. Gibbsons D, Morrissey C, Mineau P. A review of the direct and indirect effects of neonicotinoids and fipronil on vertebrate wildlife. Environmental Science and Pollution Research. 2015;22:103-118. DOI: 10.1007/s11356-014-3180-5
  21. 21. Tomlin CDS. The Pesticide Manual, A World Compendium. 14th ed. Surry, England: British Crop Protection Council; 2006. pp. 598-599
  22. 22. Chen M, Tao L, McLean J, Lu C. Quantitative analysis of neonicotinoid insecticide residues in foods: Implication for dietary exposures. Journal of Agricultural and Food Chemistry. 2014;62(26):6082-6090. DOI: 10.1021/jf501397m
  23. 23. Kumar A, Verma A, Kumar A. Accidental human poisoning with a neonicotinoid insecticide, imidacloprid: A rare case report from rural India with brief review of literature. Egyptian Journal of Forensic Sciences. 2013;3(4):123-126. DOI: 10.1016/j.ejfs.2013.05.002
  24. 24. IW W, Lin JL, Cheng CT. Acute poisoning with the neonicotinoid insecticide imidacloprid in N-methyl pyrrolidone. Journal of Toxicology: Clinical Toxicology. 2001;39(6):617-621
  25. 25. Forrester MB. Neonicotinoid insecticide exposures reported to six poison centers in Texas. Human & Experimental Toxicology. 2014;33(6):568-573. DOI: 10.1177/0960327114522500
  26. 26. Boels D, Chataignesr D. Expositions aux spécialités à base d’imidaclopride: synthèse des cas signalés aux centres antipoison français de 1999 à 2012;2013:1-44. Available from:
  27. 27. Viradiya K, Mishra A. Imidacloprid poisoning. Journal of the Association of Physicians of India. 2011;59:594-595
  28. 28. Sibia RS, Kumar AS, Dhoot SR. Imidacloprid poisoning: A modern foe. International Journal of Research in Medical Sciences. 2014;2(2):752-754. DOI: 10.5455/2320-6012.ijrms20140573
  29. 29. Vinod KV, Srikant S, Thiruvikramaprakash G, Dutta TK. A fatal case of thiacloprid poisoning. American Journal of Emergency Medicine. 2015;33:310.e5-310310.e6. DOI:
  30. 30. Iyyadurai R, George IA, Peter JV. Imidacloprid poisoning—Newer insecticide and fatal toxicity. Journal of Medical Toxicology. 2010;6(1):77-78. DOI: 10.1007/s13181-010-0041-6
  31. 31. Agarwal R, Srinivas R. Severe neuropsychiatric manifestations and rhabdomyolysis in a patient with imidacloprid poisoning. The American Journal of Emergency Medicine. 2007;25(7):844-845. DOI: 10.1016/j.ajem.2006.11.044
  32. 32. Sunny A, Chandirascharan VK, Mishra A, Jose N. Imidacloprid poisoning: Case report. Indian Journal of Forensic Medicine and Toxicology. 2015;9(2):1-4
  33. 33. Radkika RH. Self poisoning by Imicon—a case report. International Journal of Advances in Case Report. 2017;4(2):64-67. DOI:
  34. 34. Karatas AD. Severe central nervous system depression in a patient with acute imidacloprid poisoning. American Journal of Emergency Medicine. 2009;27(99):1171e5-1171e7. DOI: 10.1016/j.ajem.2009.01.006
  35. 35. Pinar HU, Dogan R, Konul M, Karaca O. Acetamiprid poisoning followed by prolonged muscle weakness. Journal of the Turkish Society of Intensive Care. 2017;15:85-87
  36. 36. Proença P, Teixeira H, Castanheira F, Pinheiro J, Monsanto EP, Vieira DN. Two fatal intoxication cases with imidacloprid: LC/MS analysis. Forensic Science International. 2005;153:75-80. DOI: 10.1016/j.forsciint.2005.04.015
  37. 37. Estrada AF, Berrouet MC, Giraldo JA. Toxicidad por neonicotinoides: revisión de tema y reporte de dos casos. Medicina U.P.B. 2016;35(1):41-46. DOI: 10.18566/medupb.v35n1.a06
  38. 38. Imamura T, Yanagawa K, Matsumoto N, Sakamoto T. Two cases of acute poisoning with acetamiprid in humans. Clinical Toxicology (Philadelphia, PA). 2010;48:851-853. DOI: 10.3109/15563650.2010.517207
  39. 39. Agha A, Bella A, Aldosary B, Kazzi ZN, AlHumaidi MA. Imidacloprid poisoning presenting as leukoclastic vasculitis with renal and hepatic dysfunction. Saudi Journal of Kidney Diseases and Transplantation. 2012;23(6):1300-1303. DOI: 10.4103/1319-2442.103584
  40. 40. Shadnia S, Moghaddam HH.Fatal intoxication with imidacloprid insecticide. American Journal of Emergency Medicine. 2008;26(5):634.e1-634634.e4. DOI: 10.1016/j.ajem.2007.09.024
  41. 41. Chwaluk P. Acute inhalation imidacloprid poisoning—A case report. Przeglaṃd Lekarski. 2010;67(8):619-620
  42. 42. Lin PC, Lin HJ, Liao YY, Guo HR, Chen KT. Acute poisoning with neonicotinoid insecticides: A case report and literature review. Basic & Clinical Pharmacology & Toxicology. 2013;112:282-286. DOI: 10.1111/bcpt.12027
  43. 43. Xing P, Xu J, Li L, Ma K. Acute severe multiorgan dysfunction syndrome with oral acetamiprid poisoning. Journal of the Formosan Medical Association. 2017;116(2):131-132. DOI: 10.1016/j.jfma.2016.06.008
  44. 44. Yeh IJ, Lin TJ, Hwang DY. Acute multiple organ failure with imidacloprid and alcohol ingestion. The American Journal of Emergency Medicine. 2010;28(2):255.e1-255.e3. DOI: 10.1016/j.ajem.2009.05.006
  45. 45. Huang NC, Lin SL, Chou CH, Hung YM, Chung HM, Huang ST. Fatal ventricular fibrillation in a patient with acute imidacloprid poisoning. The American Journal of Emergency Medicine. 2006;24(7):883-885. DOI:
  46. 46. Todani M, Kaneko H, Hayashida H, Tsuruta R, Kasaoka S, Maekawa T. Acute poisoning with neonicotinoid insecticide acetamiprid. Chūdoku Kenkyū. 2008;21(4):387-390
  47. 47. Kim JC, So BH, Kim HJ, Kim HM, Park JH, Choi SM, Park KN, Chpoi KH. Clinical characteristics of patients with neonicotinoid insecticide poisoning. Journal of the Korean Society of Clinical Toxicology. 2010;8(9):24-29
  48. 48. Harish J, Girish N, Nisarga R. Imidacloprid poisoning resulting in death. Pediatric Oncall. 2011;8(12). Available from:
  49. 49. Fuke C, Nagai T, Ninomiya K, Fukasawa M, Ihama Y, Miyazaki T. Detection of imidacloprid in biological fluids in a case of fatal insecticide intoxication. Legal Medicine (Tokyo). 2014;16(1):40-43

Written By

Nicolai Nistor, Otilia Elena Frăsinariu and Violeta Ştreangă

Submitted: August 7th, 2017 Reviewed: October 27th, 2017 Published: December 20th, 2017